Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.2.0.727
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenue $ 0 $ 0 $ 500 $ 0
Operating expenses        
Research and development 2,411 2,377 4,066 6,865
Research and development - licenses acquired 1,548 0 8,987 0
General and administrative 3,803 2,386 7,280 4,481
Total operating expenses 7,762 4,763 20,333 11,346
Loss from operations (7,762) (4,763) (19,833) (11,346)
Other income (expenses)        
Interest income 74 171 156 350
Interest expenses (352) (119) (683) (1,085)
Change in fair value of investments 1,622 0 1,407 0
Total other income (expenses) 1,344 52 880 (735)
Net loss (6,418) (4,711) (18,953) (12,081)
Less: net loss attributable to non-controlling interest 243 0 722 0
Net loss attributable to common stockholders $ (6,175) $ (4,711) $ (18,231) $ (12,081)
Basic and diluted net loss per common share $ (0.16) $ (0.13) $ (0.47) $ (0.34)
Weighted average common shares outstanding-basic and diluted 39,119,606 36,005,294 38,848,660 35,953,234